oncologic drugs advisory committee briefing document sep[removed]

First Page		Document Content
Antidotes Chelating agents Deferiprone Transfusion hemosiderosis Beta-thalassemia Iron overload Myelodysplastic syndrome Thalassemia Deferoxamine Medicine Health Chemistry		oncologic drugs advisory committee briefing document sep[removed] Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,06 MB Share Document on Facebook

	Preventability of serious transfusion reactions Martin Schipperus Jo WiersumOsselton Anita van Tilborgh Pauline Zijlker DocID: 1aRsK - View Document
	Medical Services Advisory Committee Public Summary Document DocID: 14Ow3 - View Document
	DOCX Document DocID: 14Iww - View Document
	Microsoft Word - M2M - Att A - PSD[removed]Liver Iron R2-MRI @[removed]members endorsed minutes.doc DocID: UiMV - View Document
	Medical Services Advisory Committee Public Summary Document DocID: TBM4 - View Document